Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Stock Information for Ainos Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ainos Inc.

Ainos to Relocate U.S. Headquarters to Houston, Texas; Forms ScentAI Inc.
Ainos Reports Third Quarter 2025 Financial Results
Water Tower Research Spotlights Ainos-NEXCOM Partnership as Catalyst for High-Growth Edge AI Expansion
Ainos and NEXCOM Partner to Expand AI Nose Ecosystem into Industrial Edge AI
Water Tower Research Highlights Ainos' Transition to Technology Company Following GICS Reclassification
Ainos Announces GICS Reclassification to Information Technology Sector
Ainos Expands Global IP Portfolio to 123 Patents with Seven New AI Nose Patents
Water Tower Research Highlights Ainos-Topco Alliance as Catalyst for AI Nose Global Commercialization

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.